Brief: PAION Grants Exclusive License To Mundipharma For Development And Commercialization Of Remimazolam In Japan

PAION AG

18/12/2017 05:45

Dec 18 (Reuters) - PAION AG  PA8G.DE : 
    * SAID ON SUNDAY GRANTED EXCLUSIVE LICENSE TO MUNDIPHARMA 
FOR 
DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN JAPAN 
    * EUR 1 MILLION UPFRONT PAYMENT TO PAION 
    * ADDITIONAL REGULATORY AND COMMERCIAL MILESTONE PAYMENTS OF 
UP TO 
EUR 25 MILLION 
    * ROYALTIES RANGING FROM LOW DOUBLE-DIGITS TO OVER 20% 
 
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nEQ77VR2pa 
     
 Further company coverage:  PA8G.DE   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))